skip to Main Content

Parimal Nathwani

A highly regarded life sciences industry leader and advocate with strong relationships across the academic and health research community, global industry and investors, Parimal Nathwani has been with Toronto Innovation Acceleration Partners (TIAP) since its inception in 2008, first serving as Vice President and subsequently taking on the role of President and CEO in 2020.

Parimal brings to TIAP more than 25 years of experience advancing health innovation including forming and scaling innovative new life sciences companies. His expertise includes technology transfer, intellectual property management, technology development, corporate finance, business development, alliance management and operations. Parimal has been actively involved in launching and managing more than a dozen start-up companies with activities such as raising early-stage capital, establishing strategic partnerships, recruiting management and advisors, and driving in- and out-licensing activities. Under Parimal’s leadership, TIAP has launched impactful programs such as LAB150, a collaboration with global companies Evotec SE and Amgen that has brought considerable new financial and mentorship resources to Ontario’s life sciences ecosystem to accelerate early-stage drug development.

Before joining TIAP, Parimal was a healthcare analyst with a boutique investment bank where he conducted equity research on publicly traded biotechnology companies in Canada and the U.S. He also led commercialization activities at BC Women’s and Children’s Hospital as part of his role at the University of British Columbia’s Industry Liaison Office. Parimal started his career as a research scientist at a start-up biotechnology company involved in drug discovery targeting ABC Transporters.

Parimal is currently Chair of Vasomune Therapeutics, a Director of Fibrocor Therapeutics, TRIUMF Innovations, and the Nanomedicine Innovation Network, and an Observer on the Boards of Zucara Therapeutics and Radiant Biotherapeutics. He received his MBA from Simon Fraser University and his M.Sc. from the University of British Columbia.

Back To Top